FOXO Technologies Inc. announces $1.5 million equity investment through Series A Preferred Stock issuance to support acquisitions and growth. FOXO Technologies Inc. announced that it has entered ...

(MENAFN- GlobeNewsWire - Nasdaq) WEST PALM BEACH, FLORIDA, June 04, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the ...

Therefore, JNK activation was correlated with the up-regulation of BIM expression. BIM is known to be a downstream target of forkhead box protein O (FOXO) transcription factors. Immunoblot analysis ...

WEST PALM BEACH, FL, April 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”) announces that it has filed its Annual Report on Form 10-K on April 15, 2025.

FOXO announces a non-binding acquisition agreement for two assisted-living facilities in Florida. The company agrees to $60 million for the facilities. Historic Summer Setup: 3 "Power Patterns ...

MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of commercializing epigenetic biomarker technology, today ...

MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc.™ (NYSEAM: FOXO), a leader in the field of commercializing epigenetic biomarker technology, today announced the launch of its cutting-edge ...

Shares of Minneapolis-based biotech startup Foxo Technologies Inc. began trading on the New York Stock Exchange less than a year ago. Now, the company is already in danger of being removed from ...

FOXO family members can be further regulated by distinct kinases, both positively (e.g., JNK, AMPK) and negatively (e.g., ERK-MAPK, CDK2), with additional post-translational modifications further ...

MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc.™ (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life ...